ONC
BeiGene Ltd
BIOTECHNOLOGY · HEALTHCARE
BeiGene, Ltd. (Ticker: ONC) is a pioneering global biotechnology company focused on transforming cancer treatment by developing innovative therapies that meet critical unmet medical needs in oncology. With a robust pipeline of proprietary compounds and strategic collaborations, BeiGene is well-posit...
$314.36
-0.83% ($2.63)
Volume
323,396
52W High
$385.22
52W Low
$196.45
Market Cap
$38.98B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.79
Whisper EPS
$0.90
15.0% above consensus
Last Quarter
$0.58
Current Streak
1 Miss
Avg Surprise (4Q)
+84.58%
Next Earnings Report
Reports in 56 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 26, 2026
1-Day:
-1.67%
5-Day:
-7.86%
Q3 2025
Nov 6, 2025
1-Day:
-3.73%
5-Day:
+3.40%
Q2 2025
Aug 6, 2025
1-Day:
-0.08%
5-Day:
-2.94%
Q1 2025
May 7, 2025
1-Day:
+1.59%
5-Day:
+0.43%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'25 | $1.41B | +41.0% | 86.1% | 11.6% | $124.8M |
| Q2'25 | $1.32B | +41.6% | 87.5% | 6.7% | $94.3M |
| Q1'25 | $1.12B | +48.6% | 85.2% | 1.0% | $1.3M |
| Q4'24 | $1.13B | +77.8% | 85.8% | -7.0% | -$151.9M |
| Q3'24 | $1.00B | +28.2% | 83.0% | -12.0% | -$121.4M |
| Q2'24 | $929.2M | +56.1% | 85.1% | -11.5% | -$120.4M |
| Q1'24 | $751.7M | +67.9% | 83.4% | -34.8% | -$251.2M |
| Q4'23 | $634.4M | +66.9% | 83.3% | -60.5% | -$367.6M |
Company Information
Symbol
ONC
Company
BeiGene Ltd
Market Cap
$38.98B
Sector
HEALTHCARE
Next Earnings
Apr 30, 2026
Also Reporting Soon
Companies reporting earnings around the same time as ONC
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare ONC with competitors
Side-by-side earnings comparison